Technology

Applied Therapeutics

$19.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.49 (-2.42%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell APLT and other stocks, options, and ETFs commission-free!

About APLT

Applied Therapeutics, Inc. Common Stock, also called Applied Therapeutics, is a clinical-stage biopharmaceutical company, which engages in developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY. The listed name for APLT is Applied Therapeutics, Inc. Common Stock.

CEO
Shoshana Shendelman
Employees
11
Headquarters
New York, New York
Founded
2016
Market Cap
457.73M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
84.73K
High Today
$20.32
Low Today
$19.32
Open Price
$20.04
Volume
147.19K
52 Week High
$57.39
52 Week Low
$13.58

Collections

APLT Earnings

-$1.33
-$0.89
-$0.44
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
—

You May Also Like

FGD
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure